Skip to main content
Premium Trial:

Request an Annual Quote

Cue Health Gets Authorization to Offer At-Home COVID-19 Test in Canada

NEW YORK — Cue Health said on Wednesday that it has received interim order authorization from Health Canada to sell its at-home molecular COVID-19 self-test in that country.

The isothermal nucleic acid amplification test consists of the single-use test cartridge and a wand for collecting lower nasal swab samples. It runs on the portable Cue Health Monitoring System, which was also authorized for sale in Canada, and displays test results on a connected mobile device in about 20 minutes via an app.

The test received Emergency Use Authorization from the US Food and Drug Administration in mid-2020 and CE marking in early 2021.

Cue Health said that it will begin offering the test in Canada for both professional and at-home consumer use without a prescription.

"Following the successful launch of our smart home lab platform in the US, we are pleased to now offer Canadian consumers access to our molecular COVID-19 self-test that combines accuracy, speed, and reliability," Cue Health Cofounder and CEO Ayub Khattak said in a statement.

Last month, the San Diego-based company inked a distribution deal for its COVID-19 test with Cardinal Health. It also just launched a subscription service for COVID-19 testing and virtual care.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.